HealthLynked Corp. filings document the regulatory record of a Nevada healthcare technology company whose common stock trades on the OTCQB under HLYK. Securities Act registration statements describe the company, proposed public offering disclosures, share registration mechanics, risk factors, capitalization, and related public-company information.
Current reports on Form 8-K cover material corporate events, including financing arrangements, unregistered equity-related securities, secured convertible debt obligations, executive appointments, and governance changes. The filing record also provides disclosure on capital structure, board and officer matters, related-party financing context, and the company’s reporting status, including the absence of securities registered under Section 12(b) in the cited filings.
HealthLynked Corp. (HLYKD) reported lower sales and continued losses for the quarter ended September 30, 2025. Total revenue was $388,545 versus $590,124 a year earlier, as patient service, subscription, and product revenue all declined. For the first nine months of 2025, revenue was $1,755,113 compared with $2,389,434 in the prior-year period.
The company posted a quarterly net loss of $851,800 and a nine‑month net loss of $2,603,777, though both were smaller than the prior year. Operating expenses fell year over year, helped by the absence of a $716,000 impairment charge recorded in 2024 and lower practice and overhead costs.
HealthLynked’s balance sheet remains strained. As of September 30, 2025, cash was $10,911, total assets were $1,764,557, and shareholders’ deficit widened to $5,433,415. Current liabilities of $6,744,301 included significant related‑party convertible debt, third‑party notes, and lease obligations. Management disclosed a substantial doubt about the company’s ability to continue as a going concern through November 19, 2026 without additional capital.
During the period, HealthLynked executed a 1‑for‑100 reverse stock split, reducing outstanding common shares from 284,750,832 to 2,847,873, and later agreed to sell its BTG physical therapy practice assets for $125,000 in cash.